Reporter
-
September 21, 2021
The role of polarity in early cancer
Mutations in the protein epiregulin, an EGF receptor ligand, affect larger epithelial cell reorganization and may contribute to early cancer development, Vanderbilt researchers discovered. -
September 20, 2021
Brain circuits in schizophrenia
Vanderbilt psychiatrists are probing brain circuit hyperactivity implicated in schizophrenia, with the idea that normalizing the hyperactivity may improve cognitive processes. -
September 17, 2021
Grant creates center for maternal, pediatric precision therapeutics
Vanderbilt University Medical Center has been awarded a five-year, $6 million grant from the National Institutes of Health to serve as a center of excellence for Maternal and Pediatric Precision in Therapeutics. -
September 16, 2021
Indiana University’s Embí named chair of the Department of Biomedical Informatics
Peter Embí, MD, MS, President and Chief Executive Officer for the Regenstrief Institute Inc., and professor of Medicine and Biostatistics & Health Data Science at the Indiana University School of Medicine, has been named as the new chair of Vanderbilt's Department of Biomedical Informatics. -
September 16, 2021
Structural variants in breast cancer risk genes
Vanderbilt epidemiologists conducted in-depth whole genome sequencing of breast cancer risk genes in Black women, who die at higher rates and have more aggressive disease, to discover mutations that may improve testing and treatment selection. -
September 16, 2021
VUMC team to test personalized acute heart failure treatment
Researchers at Vanderbilt have been awarded a five-year, $4 million federal grant to test whether a personalized medicine strategy will improve outcomes for patients hospitalized with acute heart failure. -
September 16, 2021
Chung receives early investigator award from ASCPT
Vanderbilt's Cecilia Chung, MD, MPH, has received the 2022 Leon I. Goldberg Early Investigator Award from the American Society of Clinical Pharmacology and Therapeutics (ASCPT).